PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2602356

Nutritional intervention in hyperlipidemia.

J E Watson
View original source ↗Export metadata ↓

Abstract

Sufficient evidence from laboratory, epidemiological, and clinical studies indicates that blood cholesterol level is an important risk factor for coronary heart disease and that lowering elevated blood cholesterol levels can reduce that risk. Hyperlipidemia can be successfully treated in most people by use of individualized, progressive, nutritional intervention strategies. Nurses must be appropriately educated in dietary assessment techniques, nutritional education, and patient counseling in order to implement these strategies effectively. Recent advances in nutritional intervention focus on a series of progressive phases for dietary reduction of fat that interact with variables associated with the individual's characteristics and life-style. Nurses in all settings see patients who require intervention to lower elevated blood cholesterol. Important contributions to therapy can be made by nurses in the areas of screening, patient education, promotion of behavioral change, monitoring dietary change and patient outcomes, and integration of nutritional intervention with other therapies. The nutritional intervention aspect of health promotion is integral to nursing practice.

Explore related subjects

Dietary FatsHumansHyperlipidemiasNutrition AssessmentPatient Education as TopicJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J E Watson. Nutritional intervention in hyperlipidemia.. https://pubmed.ncbi.nlm.nih.gov/2602356/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Psychophysics of sweet and fat perception in obesity: problems, solutions and new perspectives.

Psychophysical comparisons seem to show that obese individuals experience normal sweet and fat sensations, they like sweetness the same or less, but like fat more than the non-obese do. These psychophysical comparisons have been made using scales (visual analogue or category) that assume intensity labels (e.g. extremely) which denote the same absolute perceived intensity to all. In reality, the perceived intensities denoted by labels vary because they depend on experiences with the substances to be judged. This variation makes comparisons invalid. Valid comparisons can be made by asking the subjects to rate their sensory/hedonic experiences in contexts that are not related to the specific experiences of interest. Using this methodology, we present the evidence that the sensory and hedonic properties of sweet and fat vary with body mass index. The obese live in different orosensory and orohedonic worlds than do the non-obese; the obese experience reduced sweetness, which probably intensifies fat sensations, and the obese like both sweet and fat more than the non-obese do. Genetic variation as well as taste pathology contribute to these results. These psychophysical advances will impact experimental as well as clinical studies of obesity and other eating disorders.

Dietary Fats↗
PubMed2006

Long-chain polyunsaturated fatty acids in maternal and infant nutrition.

Homo sapiens has evolved on a diet rich in alpha-linolenic acid and long chain polyunsaturated fatty acids (LCP). We have, however, gradually changed our diet from about 10,000 years ago and accelerated this change from about 100 to 200 years ago. The many dietary changes, including lower intake of omega3-fatty acids, are related to 'typically Western' diseases. After a brief introduction in essential fatty acids (EFA), LCP and their functions, this contribution discusses our present low status of notably LCPomega3 in the context of our rapidly changing diet within an evolutionary short time frame. It then focuses on the consequences in pregnancy, lactation and neonatal nutrition, as illustrated by some recent data from our group. We discuss the concept of a 'relative' EFA/LCP deficiency in the fetus as the outcome of high transplacental glucose flux. This flux may in the fetus augment de novo synthesis of fatty acids, which not only dilutes transplacentally transported EFA/LCP, but also causes competition of de novo synthesized oleic acid with linoleic acid for delta-6 desaturation. Such conditions were encountered by us in mothers with high body mass indices, diabetes mellitus and preeclampsia. The unifying factor might be compromised glucose homeostasis. In search of the milk arachidonic acid (AA) and docosahexaenoic acid (DHA) contents of our African ancestors, we investigated women in Tanzania with high intakes of freshwater fish as only animal lipid source. These women had milk AA and DHA contents that were well above present recommendations for infant formulae. Both studies stimulate rethinking of 'optimal homeostasis'. Subtle signs of dysbalanced maternal glucose homeostasis may be important and observations from current Western societies may not provide us with an adequate basis for dietary recommendations.

Dietary Fats↗